MEDAG enhances breast cancer progression and reduces epirubicin sensitivity through the AKT/AMPK/mTOR pathwayZhiyu Li, Shengrong Sun|Cell Death and Disease|2021Cited by 32
NRBP2 Functions as a Tumor Suppressor and Inhibits Epithelial-to-Mesenchymal Transition in Breast CancerZhiyu Li, Xiongjie Zhang|Frontiers in Oncology|2021Cited by 7